The causal relationship between blood cholesterol and atherosclerotic cardiovascular disease (ASCVD) required many decades of research to establish and validate, and initial treatments focused on diet. However, in the last 50 years, and particularly the last 10, we have made great strides in lipid-lowering therapies that have been accelerated by the use of genomics for target identification and biotechnology for drug development.

Article By:

Christie M. Ballantyne, MD, FNLA
0
No votes yet

Telehealth, defined as a virtual platform to perform medical care services, has become an integral part of how we conduct healthcare in the last decade. The rapid uptake of telemedicine can be largely attributed to the COVID-19 pandemic that has overtaken our lives for the past two years. However, the pandemic has not been the only contributor, others include advances in patient access to and healthcare’s investment in technology.

Article By:

Laney K. Jones, PharmD, CLS, FNLA
0
No votes yet

The NLA has long prided itself on developing timely and relevant scientific statements, which is also a key strategy to help the NLA achieve its mission, “to enhance the practice of lipid management in clinical medicine.” Developing scientific statements is an important responsibility of the NLA, and its members have dedicated many hours to it as these documents take a herculean effort to produce.

Article By:

Dave L. Dixon, PharmD, CLS, FNLA

Scientific Statements Committee Co-Chair

James A. Underberg, MD, MS, FNLA

Scientific Statements Committee Founder

0
No votes yet

The NLA established the Foundation of the National Lipid Association in 2008 when Dr. Paul Ziajka and the late Dr. Ralph Vicari dissolved the Florida Lipid Foundation and donated its funds to the NLA. The mission of the Foundation is to improve the welfare of patients and families affected by cholesterol and triglyceride problems.

Article By:

Anne C. Goldberg, MD, FNLA

Foundation of the NLA President 2008-2021

James A. Underberg, MD, MS, FNLA

Foundation of the NLA President, 2021-Present

0
No votes yet

From its very start in 2002, the National Lipid Association planned to pursue establishment of a scientific journal that would complement LipidSpin by publishing high level original research, case studies, influential reviews, and editorial commentary in clinical lipidology. Virgil Brown led the effort as we partnered with Elsevier, in our view the premier scientific publisher. The Journal of Clinical Lipidology (JCL) launched in 2007.

Article By:

John R. Guyton, MD, FNLA

President, National Lipid Association, 2004-2005

Editor in Chief, Journal of Clinical Lipidology

0
No votes yet

LipidSpin is a journal filled with current, relevant, evidence-based information dedicated to lipid science and cardiovascular disease prevention, and is specifically directed towards meeting fundamental educational needs of the membership of the NLA. This year, we celebrate the journal’s 22nd birthday. Yes, LipidSpin is older than the NLA itself!

Article By:

Kaye-Eileen Willard, MD, FNLA

LipidSpin Co-Editor

Lynne T. Braun, PhD, CNP, CLS, FNLA

LipidSpin Co-Editor

0
No votes yet

Mentorship is, and always has been, a crucial component of the NLA. As a growing field, NLA members pride themselves on educating their fellow colleagues, reaching out to up-and-coming clinicians, and creating better health professionals for patients. Below you will find the experiences and thoughts of members on mentorship in the NLA:

Article By:

Anne C. Goldberg, MD, FNLA

President, National Lipid Association, 2007-2008

Chief Science Officer

Alan S. Brown, MD, FNLA

President, National Lipid Association, 2018-2019
 

Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA

National Lipid Association Board Member

Daniel E. Soffer, MD, FNLA

National Lipid Association Executive Committee Chair

0
No votes yet

From its early beginnings, piecemealed from a variety of medical school textbooks to the latest information readily available at the click of a button, the NLA has experienced tremendous growth in the education of its members, colleagues, and the general public; and recognizing those who have achieved excellence through certification.

Article By:

Peter H. Jones, MD, FNLA

President, National Lipid Association, 2005-2006

Don. P. Wilson, MD, FNLA

President of ABCL

Dave L. Dixon, PharmD, CLS, FNLA

President of ACCL

Chris DeVille

Director of Education

0
No votes yet

The National Lipid Association owes much of its success to the founding lipid legend members, not only for their dedication to the organization but for hiring Chris Seymour as their Executive Director. When the Southeast Lipid Association began in 1997, John R. Guyton, MD, FNLA, had heard of Chris Seymour’s abilities through his prior directorship of the American Association of Clinical Endocrinologists.

Article By:

JOSEPH J. SASEEN, PharmD, CLS, FNLA

President, National Lipid Association, 2020-2022

0
No votes yet

Since its inception, the National Lipid Association has produced significant contributions to the scientific literature, creating practical guidance for Clinical Lipid Specialists, as well as the general clinical and public health communities. These publications have cemented NLA’s prominence in pursuit of its mission to enhance the practice of lipid management in clinical medicine.

Article By:

Terry A. Jacobson, MD, FNLA

President, National Lipid Association, 2014-2015

Kevin C. Maki, PhD, CLS, FNLA

President, National Lipid Association, 2022-2023

0
No votes yet